Breaking Down Zhuhai Orbita Aerospace Science & Technology Co.,Ltd Financial Health: Key Insights for Investors

Zhuhai Orbita's latest quarter and trailing figures paint a mixed picture that investors can't ignore: quarterly revenue fell to CNY 51.41 million (down 24.71% year‑over‑year) and TTM revenue sits at CNY 206.25 million (a 24.64% decline), while the company reported a TTM net loss of CNY 305.38 million (loss per share CNY 0.44) even as adjusted Q2 2025 net income improved to CNY 9.4 million; valuation and capital structure raise red flags with a market cap of CNY 8.91 billion, a P/S of 46.86 and a debt‑to‑equity ratio of 14.89, counterbalanced by CNY 232.44 million in cash (cash per share CNY 0.33) and a current ratio of 1.65 - yet analysts still point to upside from projected EBIT expansion to ~CNY 300 million by 2026, a potential revenue CAGR of 10% to CNY 1.2 billion, and ongoing R&D investment of ~CNY 80 million annually, all of which make it essential to parse revenue trends, profitability metrics, liquidity, valuation multiples and partnerships in the detailed breakdown ahead.

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) - Revenue Analysis

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd reported material revenue contraction across recent periods, with both quarterly and annual metrics pointing to persistent top-line pressure while valuation multiples remain elevated relative to sales.

• Quarter (ending 2025-06-30) revenue: CNY 51.41 million, down 24.71% year-over-year.
• Trailing twelve months (TTM) revenue as of 2025-06-30: CNY 206.25 million, a 24.64% decline YoY.
• Full-year 2024 revenue: CNY 212.08 million, down 39.86% from 2023's CNY 352.66 million.
• Revenue per share (TTM ending 2025-06-30): CNY 0.32.
• Quarterly revenue growth (most recent quarter): 14.20% (sequential/quarter-over-quarter indication).
• Revenue per employee: CNY 366,350 across 563 employees.
• Market capitalization (2025-07-01): CNY 8.91 billion, implying a P/S ratio of 46.86 on TTM revenue.

Key implications and investor considerations:

• The steep YoY declines (near 25% TTM and ~40% in 2024 vs 2023) indicate demand or contract execution challenges; quarter revenue decline of 24.71% underscores ongoing softness.
• Despite recent sequential quarterly revenue growth of 14.20%, the high P/S of 46.86 signals that market valuation assumes substantial recovery or high-margin future prospects; risk of multiple compression is material if top-line recovery stalls.
• Revenue per employee of CNY 366,350 suggests moderate productivity for an aerospace-related firm; productivity trends should be tracked alongside headcount changes and margin expansion initiatives.
• Absolute scale remains modest (TTM CNY 206.25M) versus market cap, so any revenue improvement or deterioration will disproportionately affect valuation.

For strategic context on the company's stated direction and priorities that could influence revenue trajectories, see: Mission Statement, Vision, & Core Values (2026) of Zhuhai Orbita Aerospace Science & Technology Co.,Ltd.

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) - Profitability Metrics

Key profitability indicators for Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) reflect recent operational stress alongside early signs of margin stabilization in non-GAAP measures. Relevant figures are presented below.

• TTM net income (as of June 30, 2025): loss of CNY 305.38 million; loss per share: CNY 0.44.
• Profit margin (TTM ending March 31, 2025): -134.52%.
• Operating margin (TTM ending March 31, 2025): -4.29%.
• Return on assets (TTM): -5.75%.
• Return on equity (TTM): -15.58%.
• Adjusted (non-GAAP) net income - Q2 2025: CNY 9.4 million; Q1 2025: loss of CNY 31.1 million.

EBIT trajectory (management / analyst projection):

• 2023: CNY 200 million (baseline).
• 2024: projected intermediate growth (company guidance/analyst consensus).
• 2025: continuing growth toward target.
• 2026: approximately CNY 300 million (projected).

For company background and broader context, see: Zhuhai Orbita Aerospace Science & Technology Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) - Debt vs. Equity Structure

• Total debt to equity ratio: 14.89 (as of 2025-03-31), indicating debt materially exceeds equity on the balance sheet basis used.
• Total cash on hand: CNY 232.44 million (CNY 0.33 per share).
• Current ratio: 1.65 - adequate coverage of short-term liabilities by short-term assets.
• Book value per share: CNY 2.55 (as of 2025-03-31).
• Market capitalization: CNY 8.91 billion (as of 2025-07-01) with P/B = 5.02.
• Enterprise value / EBITDA: -54.29, reflecting negative EBITDA and implying EV is being measured against losses.

• Short-term: current ratio of 1.65 and CNY 232.44M cash provide a buffer for near-term obligations, but cash per share is modest at CNY 0.33.
• Leverage: the 14.89 debt-to-equity ratio signals high leverage relative to equity; sensitivity to interest or refinancing risk is elevated if earnings fail to recover.
• Profitability linkage: a negative EBITDA (EV/EBITDA = -54.29) means operating cash generation is insufficient, which raises reliance on cash reserves, asset sales, or new financing to service debt.

• Market pricing vs. book: P/B of 5.02 implies the market values growth or intangible assets well above net book equity (book value/share CNY 2.55 vs. market-implied book multiple).
• Enterprise value distortions: negative EBITDA makes EV/EBITDA an unreliable cross-company comparator and signals investors should focus on cash flow path and earnings recovery catalysts.

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) - Liquidity and Solvency

• Total cash on hand (Mar 31, 2025): CNY 232.44 million (CNY 0.33 per share)
• Current ratio: 1.65 - sufficient coverage of short-term liabilities
• Total debt to equity ratio: 14.89 - relatively high leverage versus equity
• Book value per share (Mar 31, 2025): CNY 2.55
• Enterprise value / EBITDA: -54.29 - reflects negative EBITDA
• Market capitalization (Jul 1, 2025): CNY 8.91 billion; P/B ratio: 5.02

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) - Valuation Analysis

• Market capitalization (as of July 1, 2025): CNY 8.91 billion.
• TTM Price-to-Sales (P/S): 46.86 - very high relative to peers and historical norms.
• TTM Price-to-Book (P/B): 5.02 - indicates a substantial premium to book value.
• Enterprise Value / Revenue (EV/Rev): 41.37 - signals strong market expectation for future growth.
• Enterprise Value / EBITDA (EV/EBITDA): -54.29 - reflects negative EBITDA and enterprise-level losses.

• High P/S and EV/Rev imply investors price in substantial future revenue growth or strategic value beyond current sales.
• Negative EV/EBITDA underscores current operating losses or large non-cash adjustments depressing EBITDA.
• Elevated P/B suggests investor willingness to pay well above reported net assets, possibly for intellectual property, contracts, or growth optionality.

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) - Risk Factors

• Net loss: CNY 305.38 million (TTM) - loss per share: CNY 0.44.
• Profitability pressure: profit margin of -134.52% (TTM), indicating losses greatly exceed revenue for the period measured.
• Operational strain: operating margin of -4.29% (TTM), reflecting negative operating performance before non-operating items.
• Negative returns: return on assets (TTM) -5.75%; return on equity (TTM) -15.58%.
• Negative EV/EBITDA: enterprise value to EBITDA -54.29, signaling negative EBITDA and valuation stresses.
• Leverage concerns: total debt to equity ratio 14.89, indicating a high proportion of debt relative to equity.

• Capital erosion and equity dilution risk if losses persist and management seeks to raise equity capital.
• Refinancing and solvency risk due to high debt-to-equity and negative operating cash generation.
• Valuation ambiguity: negative EBITDA and EV/EBITDA make traditional valuation metrics unreliable.
• Margin volatility: an extreme negative profit margin suggests one-time or recurring factors sharply depressing revenue recognition or inflating costs.
• Investor confidence risk: sustained negative ROE and ROA undermine returns expectations and can pressure share liquidity and price action.

Zhuhai Orbita Aerospace Science & Technology Co.,Ltd (300053.SZ) - Growth Opportunities

• Analyst consensus projects a 10% CAGR over the next five years, with revenue potentially reaching CNY 1.2 billion by 2026.
• Annual R&D investment of roughly CNY 80 million, supporting rapid product iteration and competitive differentiation.
• Active strategic commercial partnerships, notably with China Telecom (2023) to integrate satellite technology into 5G networks.
• International research collaborations, including engagement with the European Space Agency (ESA) initiated in 2023.
• Academic and industry R&D alliances with institutions and firms such as Tsinghua University and Huawei, enhancing technical depth and access to commercial channels.

• Market Opportunity: With the global satellite market expanding from ~$126B (2021) to a projected ~$209B by 2027, addressable markets for satellite communications, IoT backhaul, and 5G-satellite integration are growing materially.
• Commercial Upside: Integration with China Telecom and partnerships with Huawei open direct commercial channels for constellation services, enterprise connectivity, and government contracts.
• Research & Product Pipeline: Sustained CNY 80M annual R&D fuel supports new payloads, software-defined satellite capabilities, and higher-margin service offerings.